Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of respiratory infections in children. Palivizumab (PZ) is the only RSV-specific immunoprophylaxis approved by the U.S. Food and Drug Administration. Mutations leading to amino acid substitutions in the PZ binding site of the RSV F prote...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Virol
Main Authors: Oliveira, Danielle B.L., Iwane, Marika K., Prill, Mila M., Weinberg, Geoffrey A., Williams, John V., Griffin, Marie R., Szilagyi, Peter G., Edwards, Kathryn M., Staat, Mary A., Hall, Caroline B., Durigon, Edison L., Erdman, Dean D.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Science 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172275/
https://ncbi.nlm.nih.gov/pubmed/25766983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2015.01.016
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki